Clinical trial
Novel Breast Cancer Biomarkers and Their Use for Guiding and Monitoring Response to Chemotherapy
NCT01722851 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Breast Cancer Biomarkers and Their Use for Guiding and Monitoring Response to Chemotherapy
- Lead sponsor
- Cancer Trials Ireland
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- December 31, 2021
- Enrollment
- 255 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, newly diagnosed breast cancer, recurrent breast cancer